INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-38066 | Pharmaceuticals and Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Infectious Disease Testing Using PCR for IVD Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET
7.1 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING USING PCR FOR IVD MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Sysmex
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Ortho Clinical Diagnostics
16.3 Bayer
16.4 Bio-Rad Laboratories
16.5 Oxford Nanopore
16.6 Roche Diagnostics
16.7 Cepheid
16.8 Hologic
16.9 Qiagen
16.10 BioMerieux
16.11 Siemens Healthineers
16.12 Merck
16.13 Abbott Laboratories
16.14 Thermo Fisher
16.15 Codexis
16.16 BD
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredIndirect Detection
Direct Detection
Major Downstream Industry Covered
Hospitals
Laboratory
Other
Companies
Sysmex
Ortho Clinical Diagnostics
Bayer
Bio-Rad Laboratories
Oxford Nanopore
Roche Diagnostics
Cepheid
Hologic
Qiagen
BioMerieux
Siemens Healthineers
Merck
Abbott Laboratories
Thermo Fisher
Codexis
BD
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.